1. Home
  2. News
  3. Hydrix Limited
  4. AngelMed completes its first USA commercial Guardian implant
More Hydrix Limited news
Hydrix LimitedASX: HYD

AngelMed completes its first USA commercial Guardian implant

Aug 1, 2021 at 11:29 PM EDT · Issued by Hydrix Limited

Filed with ASX · Aug 1, 2021 at 11:29 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/angelmed-completes-its-first-usa-commercial-guardian-implant

Hydrix Limited on 6ix

Story so far

  • Hydrix completes TGA submission for AngelMed Guardian SystemJul 21, 2021
  • Investor Presentation - AngelMed Guardian FDA ApprovalJun 30, 2021
  • AngelMed receives FDA approval for Guardian upgraded batteryJun 28, 2021

Earlier from Hydrix

  • Hydrix completes TGA submission for AngelMed Guardian SystemJul 20, 2021
  • Investor Presentation - AngelMed Guardian FDA ApprovalJun 30, 2021
  • AngelMed receives FDA approval for Guardian upgraded batteryJun 27, 2021
  • 2020 AGM - Executive Chairmans PresentationDec 11, 2020
  • First in human trials of Phyzhon Health PHYRARI FFR-WIREDec 9, 2020

Later from Hydrix

  • Commercial arrangement between Hydrix and MemphasysAug 31, 2021
  • FY2021 Letter from Executive ChairmanAug 31, 2021
  • FY2021 Appendix 4E and Financial ReportAug 31, 2021
  • MEM: Reaches settlement agreement with HydrixAug 31, 2021
  • Quarterly Activities ReportJan 30, 2022
All Hydrix news releases↗

Follow Hydrix into a list and get an email when it puts out news.

Follow Hydrix
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer